SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,581.00 152.05
( 0.19%)

Global Indices

Nasdaq

54,113.09 913.68
(1.72%)

Dow Jones

7,758.57 137.07
(1.80%)

Hang Seng

66,265.57 2,308.04
(3.61%)

Nikkei 225

10,890.39 32.69
(0.30%)

Forex

USD-INR

95.29 -0.10
(-0.11%)

EUR-INR

109.78 -0.22
(-0.20%)

GBP-INR

128.18 -0.43
(-0.33%)

JPY-INR

0.61 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

391.1437121

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

37.88

91987.36

EPS(TTM)

Face Value()

Div & Yield %

41.81

0.25

Back

S I Capital & Financial Services standalone net profit declines 30.00% in the June 2026 quarter

Jul 24,2026

Net profit of S I Capital & Financial Services declined 30.00% to Rs 0.14 crore in the quarter ended June 2026 as against Rs 0.20 crore during the previous quarter ended June 2025. Sales rose 28.24% to Rs 1.09 crore in the quarter ended June 2026 as against Rs 0.85 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.09	0.85	28
OPM %	33.94	47.06	-
PBDT	0.15	0.21	-29
PBT	0.14	0.20	-30
NP	0.14	0.20	-30

78,581.00 152.05 ( 0.19%)

54,113.09 913.68 (1.72%)

7,758.57 137.07 (1.80%)

66,265.57 2,308.04 (3.61%)

10,890.39 32.69 (0.30%)

95.29 -0.10 (-0.11%)

109.78 -0.22 (-0.20%)

128.18 -0.43 (-0.33%)

0.61 0.00 (0.31%)